Neurotherapia

• Marianna Kiraly

  Vice president, research and development

Sources: reporter.nih.gov

• National Institute on Aging

  R44, Preclinical toxicology in animals to prove the safety of a novel Alzheimer's Disease treatment, R44AG102269, US$1.2m, 2026–2028, 8 Sept 2026

Sources: reporter.nih.gov

• Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders

  Consulting or advice, 19 Dec 2025

Sources: pubmed.ncbi.nlm.nih.gov